Tag: COVID-19
-
Zentek (ZEN.V) took a years long path to figure out its incredible biotech potential
Today I found myself going down an investment rabbit hole, chasing information about a company that, to be honest, is wallowing, and has for a while. Unmarketed. Unexplained. Unsimple. Unloved. The company is Zentek (ZEN.V). Back in the day, it was an exploration play known as Zen Graphene Solutions that was more focused on developing…
-
Revive Therapeutics (RVV.C) takes on long covid with new phase 2/3 FDA protocol
Allow me to back into the lede a bit here. THE STORY OF ROCKERFELLER VS THE WORMS In the early part of the 20th century, the American South was known colloquially as ‘the hookworm belt.’ Hookworms are parasites that like a human host. They corkscrew into your feet when you walk by them barefoot, travel…
-
![Revive Therapeutics (RVV.C) finds multiple research options moving forward]()
Revive Therapeutics (RVV.C) finds multiple research options moving forward
In Canada, if you look backwards over the timeline, you’ll often find public companies have been other things back in the day. Risen, fallen, tapped out, rolled back, reemerged as a whole new thing. Sometimes this happens several times before a business model catches. Revive Therapeutics (RVV.C) is that rare Canadian smallcap that, while it…
-
![Revive Therapeutics (RVV.C): Covid came, Covid went, but Revive is still fighting]()
Revive Therapeutics (RVV.C): Covid came, Covid went, but Revive is still fighting
Back at the dawn of Covid-19, a load of public companies started pumping out news releases that claimed they were going to be entering the medical space. In the best tradition of Howe Street, long dormant mining companies suddenly became med-tech deals, hawking everything from clear plastic checkout counter dividers to virus sniffing doorways to…
-
![Core Story: FendX Technologies (FNDX.C) repels and kills pathogens and viruses]()
Core Story: FendX Technologies (FNDX.C) repels and kills pathogens and viruses
We went after this company as a client because there are three things about it that make me swoon. 1: The CEO has done it all before, in this industry, and has more knowledge about her domain than most 2: The product is needed, necessary, cutting edge, and quickly developing with their academic partners 3:…
-
![Entering a New Age of Abundance: Are We in the Midst of a Commodities Supercycle?]()
Entering a New Age of Abundance: Are We in the Midst of a Commodities Supercycle?
In the wake of the COVID-19 pandemic, the global economy has been in a state of flux. Among the market sectors experiencing significant shifts, commodities have shown signs that might suggest we are entering a new supercycle. But what is a commodity supercycle, and what does it imply for the global market and, specifically, the…
-
![Put on your tinfoil hats, it’s time to talk about 5G]()
Put on your tinfoil hats, it’s time to talk about 5G
The Future Is Now, Old Man Believe it or not, 5G wasn’t responsible for the COVID-19 pandemic. Hot take, I know. Despite this, there were over 90 arson and sabotage attacks on mobile masts in the United Kingdom (UK) at the peak of this conspiracy theory in 2020. The year is now 2022, however, some still…
-
![MYND Life Sciences (MYND.C) provides unorthodox route to better mental health]()
MYND Life Sciences (MYND.C) provides unorthodox route to better mental health
We’re living in interesting times and I mean that in the Chinese curse kind of way. We can’t seem to stop to catch our breath when it comes to this pandemic, and the news sources we trust to keep us informed can’t seem to get the story straight. The result is more isolation, frustration, and…
-
![Today’s Idea: Revive Therapeutics (RVV.C) offers treatments for a mixed-bag of diseases, but the upside is all yours]()
Today’s Idea: Revive Therapeutics (RVV.C) offers treatments for a mixed-bag of diseases, but the upside is all yours
We’re closing in on three years now and it’s becoming hard to believe there was a market before COVID-19. We can barely remember it. Cannabis was a thing briefly, and before that we had crypto, and after cannabis’ untimely deflation in the summer of 2018, we were looking for the next source of market exuberance.…
-
![To Invest or Not: BetterLife Pharma (BETR.C)]()
To Invest or Not: BetterLife Pharma (BETR.C)
In this episode, we look at BetterLife Sciences (BETR.C), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders. We check out their product pipeline and stock price to get a better idea of what the future may hold for potential investors.
